Garuda Therapeutics

Garuda Therapeutics was a clinical-stage biotechnology company founded in 2021 by Sean Morrison and David Scadden and headquartered in Massachusetts (Cambridge, later Natick), developing off-the-shelf, self-renewing, HLA-compatible, transgene-free hematopoietic (blood) stem cell therapies intended to remove the dependency on a matched donor or on patient cells in the treatment of hematologic malignancies, sickle cell disease, beta-thalassemia and bone marrow failure. It raised roughly $184M across a $72M Series A and a $50M Series A-1 closed in March 2025, backed by OrbiMed Advisors, Northpond Ventures, Cormorant Asset Management and Kyowa Kirin. It is a therapeutics developer, not a software company: it never published an API, SDK, developer portal or machine-readable specification, and its website garudatx.com no longer serves company content and now resolves to a GoDaddy parking lander.

Garuda Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Cell Therapy, and Stem Cells.

3.9/100 minimal Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyBiotechnologyTherapeuticsCell TherapyStem CellsLife SciencesHealthcareDefunct

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 3.9/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Commercial Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 3.9 / 9
Regulatory Posture 0.0 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/garuda-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Other 1

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: garuda-therapeutics
name: Garuda Therapeutics
description: 'Garuda Therapeutics was a clinical-stage biotechnology company founded in 2021 by Sean Morrison and David Scadden
  and headquartered in Massachusetts (Cambridge, later Natick), developing off-the-shelf, self-renewing, HLA-compatible, transgene-free
  hematopoietic (blood) stem cell therapies intended to remove the dependency on a matched donor or on patient cells in the
  treatment of hematologic malignancies, sickle cell disease, beta-thalassemia and bone marrow failure. It raised roughly
  $184M across a $72M Series A and a $50M Series A-1 closed in March 2025, backed by OrbiMed Advisors, Northpond Ventures,
  Cormorant Asset Management and Kyowa Kirin. It is a therapeutics developer, not a software company: it never published an
  API, SDK, developer portal or machine-readable specification, and its website garudatx.com no longer serves company content
  and now resolves to a GoDaddy parking lander.'
url: https://raw.githubusercontent.com/api-evangelist/garuda-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-16'
modified: '2026-08-16'
tags:
- Company
- Biotechnology
- Therapeutics
- Cell Therapy
- Stem Cells
- Life Sciences
- Healthcare
- Defunct
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: SecondaryMarketListing
  name: Forge Global secondary-market listing
  url: https://forgeglobal.com/garuda-therapeutics_stock/
x-website-status:
  domain: garudatx.com
  serves_company_content: false
  observed: '2026-08-16'
  state: parked
  note: Deliberately NOT wired as a Website pointer. garudatx.com returns a 114-byte HTML stub that redirects to /lander,
    the GoDaddy parking single-page app. The Wayback Machine shows the real company site through 2025-01-22, Australian online-casino
    SEO spam at the 2025-10-09 snapshot, and a ~538-byte holding page from 2026-01-20 onward. garudatherapeutics.com 301s
    to a HugeDomains for-sale listing. The only live URL for this company is a trading-venue listing, which is a venue page
    and not a company web presence (roadmap#56), so it is typed SecondaryMarketListing rather than Website.
x-enrichment:
  date: '2026-08-16'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: defunct
  detail: Garuda Therapeutics is a clinical-stage cell-therapy developer that never had a developer surface, and its domain
    garudatx.com has since left its control — it served Australian online-casino SEO spam in October 2025 and now returns
    a 114-byte stub redirecting to a GoDaddy parking lander, while garudatherapeutics.com 301s to a HugeDomains for-sale page.
  evidence:
  - url: https://garudatx.com/
    status: 200
  - url: https://garudatx.com/lander
    status: 200
  - url: https://garudatx.com/.well-known/agent-card.json
    status: 200
  - url: https://garudatx.com/openapi.json
    status: 200
  - url: https://garudatherapeutics.com/
    status: 200
  checked: '2026-08-16'